Elsevier

Heart Failure Clinics

Volume 6, Issue 4, October 2010, Pages 453-469
Heart Failure Clinics

Left Ventricular Noncompaction: A New Form of Heart Failure

https://doi.org/10.1016/j.hfc.2010.06.005Get rights and content

Section snippets

LVNC: overview

This disorder has been considered to be a rare disease and has been identified by a variety of names including spongy myocardium, fetal myocardium, noncompaction of the left ventricular myocardium, hypertrabeculation syndrome, and LVNC.2, 4, 5, 6, 7 As noted earlier, the abnormality is believed to represent an arrest in the normal process of myocardial compaction, the final stage of myocardial morphogenesis, resulting in persistence of multiple prominent ventricular trabeculations and deep

Historical delineation of LVNC

LVNC was first described by Grant11 in 1926 and, in the past 75 years, has been identified in association with a variety of congenital heart malformations affecting the coronary arteries, left and right ventricular outflow tracts, and interventricular and interatrial septa.11, 12, 13, 14, 15, 16 In the past 20 years, isolated LVNC (ie, not associated with CHD) has also been described, albeit more rarely.17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29

Normal cardiac structure

Cardiac muscle fibers comprise separate cellular units (myocytes) connected in series.30 In contrast to skeletal muscle fibers, cardiac fibers do not assemble in parallel arrays but bifurcate and recombine to form a complex three-dimensional network. Cardiac myocytes are joined at each end to adjacent myocytes at the intercalated disc, the specialized area of interdigitating cell membrane (Fig. 1). The intercalated disc contains gap junctions (containing connexins), mechanical junctions,

Pathology of LVNC

In the early embryo, the heart is a loose interwoven mesh of muscle fibers.16 The developing myocardium gradually condenses, and the large spaces within the trabecular meshwork disappear, condensing and compacting the ventricular myocardium and solidifying the endocardial surfaces. Trabecular compaction is normally more complete in the LV than in the myocardium of the right ventricle (RV). The situations in which this compacting pathway fails are believed to be caused by an arrest in

Incidence of LVNC

The incidence and prevalence of LVNC is unknown but the disease is considered to be rare. Ritter and colleagues17 reported the prevalence of isolated LVNC to be 0.05% of all adult echocardiographic examinations in a large institution. No other reliable data have been reported to date.

Clinical features and diagnosis of LVNC

LVNC commonly presents in infancy with signs and symptoms of congestive heart failure (CHF).4, 7 Echocardiographically, this disorder is characterized by systolic dysfunction associated with a dilated, hypertrophic LV. The characteristic deep trabeculations are typically noted in the LV apex and lateral wall; regional wall motion abnormalities are common. Multiple forms of LVNC are reported. One group of cases of LVNC occurs in the absence of other structural heart disease and is believed to be

Subtypes of LVNC

Although an increasing number of clinicians are beginning to recognize the clinical features of LVNC, several key points have failed to be described. One of the important issues in the diagnosis and outcomes of these patients, particularly in childhood, is the specific LVNC phenotype that exists in any 1 patient. There are at least 7 different phenotypes of LVNC and these different phenotypes have different outcomes (Fig. 2). The subtypes include the following:

Imaging of LVNC

Echocardiography has been used to diagnose and describe LVNC. Recently, Punn and Silverman45 investigated LVNC using the 16-segment model described by the American Heart Association and the American Society of Echocardiography in 44 children with LVNC. Using the ratio of noncompaction to compaction, the investigators analyzed the 16 segments and determined whether severity was correlated with poor outcomes in these affected children. The 16-segment noncompaction/compaction ratio, shortening

Electrocardiography in LVNC

The ECG in patients with LVNC is typically abnormal and commonly has giant voltages (Fig. 3).2, 7 These patients, particularly the childhood forms of LVNC, may be associated with pre-excitation. In approximately 30% of patients with LVNC, particularly children, there is extreme midprecordial voltages that mimic the ECG seen in Pompe disease. Arrhythmias, including supraventricular tachycardia and ventricular tachycardia, are common and dangerous accompaniments to all subtypes of LVNC.

Clinical genetics of LVNC

LVNC most commonly has X-linked recessive or autosomal dominant inheritance.7, 8 In X-linked LVNC, female carriers have not been found to develop frank clinical disease, and are echocardiographically normal. Consistent with X-linked inheritance, no male-to-male transmission of the disease occurs.19 In some cases of LVNC without CHD, and most, if not all, cases of the form associated with CHD, autosomal dominant inheritance is seen in familial cases.7, 8 When LVNC is associated with CHD, the

Molecular genetics of LVNC

A genetic cause of isolated LVNC was initially described by Bleyl and colleagues19 when they identified mutations in the gene G4.5/TAZ in patients and carrier women. This gene, known as G4.5 or tafazzin (TAZ), encodes a novel protein family (tafazzins) with unclear function, and is also responsible for Barth syndrome (BTS)47 and other forms of infantile cardiomyopathies.48, 49 BTS is a clinical association of myocardial dysfunction, neutropenia, skeletal myopathy, abnormal mitochondria, organic

Final Common Pathway Hypothesis

To put the mechanisms responsible for cardiovascular disorders into perspective, a unifying hypothesis has been developed that helps to predict the central targets and interacting, modifying cascades that, when disordered, result in a specific phenotype. For instance, familial hypertrophic cardiomyopathy (FHC) is a genetically heterogeneous disease in which 17 genes have been identified to cause this phenotype when mutated.61 As previously noted, the mutated gene most commonly encodes a

Animal models of LVNC

A significant number of mouse models with cardiomyopathy have been described in the past several years. However, few have a clear phenotype similar to LVNC, although several have had a hypertrophic, dilated heart with systolic dysfunction. One of the best models of LVNC to date is the FKBP12-deficient mouse, but others exist.73, 74 Models deficient in the sarcoglycan complex and its associated proteins (ie, sarcospan, syntrophin) have commonly been shown to develop a hypertrophic, dilated heart.

Therapy and outcome

The specific therapy depends on the clinical and echocardiographic findings. In patients with systolic dysfunction and heart failure, anticongestive therapy identical to those used in patients with DCM is appropriate. In particular, ACE inhibitors such as captopril and enalapril are useful, as well as β-adrenergic blocking agents such as metoprolol or carvedilol. Diuretics may also be needed. However, in those patients exhibiting findings more consistent with an HCM or diastolic dysfunction

BTS

Initially described as X-linked cardioskeletal myopathy with abnormal mitochondria and neutropenia by Neustein and colleagues51 and Barth and colleagues,50 this disorder typically presents in male infants as CHF associated with neutropenia (cyclic) and 3-methylglutaconic aciduria.52 Mitochondrial dysfunction is noted on electron microscopy and electron transport chain biochemical analysis. In addition, abnormalities in cardiolipin have been noted.103 Echocardiographically these infants

First page preview

First page preview
Click to open first page preview

References (123)

  • Y. Capetanaki

    Desmin cytoskeleton: a potential regulator of muscle mitochondrial behaviour and function

    Trends Cardiovasc Med

    (2002)
  • T. Furukawa et al.

    Specific interaction of the potassium channel beta-subunit iph with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system

    J Mol Biol

    (2001)
  • B. Pinamonti et al.

    Left ventricular involvement in right ventricular dysplasia

    Am Heart J

    (1992)
  • R. Punn et al.

    Cardiac segmental analysis in left ventricular noncompaction: experience in a pediatric population

    J Am Soc Echocardiogr

    (2010)
  • F. Thuny et al.

    Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography

    Arch Cardiovasc Dis

    (2010)
  • P. D'Adamo et al.

    The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies

    Am J Hum Genet

    (1997)
  • J. Johnston et al.

    Mutation characterization and genotype-phenotype correlation in Barth syndrome

    Am J Hum Genet

    (1997)
  • P.G. Barth et al.

    An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leukocytes

    J Neurol Sci

    (1983)
  • R.I. Kelley et al.

    X-linked dilated cardiomyopathy with neutropenia, growth retardation and 3-methylglutaconic aciduria

    J Pediatr

    (1991)
  • T. Ino et al.

    Dilated cardiomyopathy with neutropenia, short stature, and abnormal carnitine metabolism

    J Pediatr

    (1988)
  • M. Vatta et al.

    Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction

    J Am Coll Cardiol

    (2003)
  • L. Shan et al.

    SCN5A variants in Japanese patients with left ventricular noncompaction and arrhythmia

    Mol Genet Metab

    (2008)
  • S. Tang et al.

    Left ventricular noncompaction is associated with mutations in the mitochondrial genome

    Mitochondrion

    (2010)
  • L. Thierfelder et al.

    α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

    Cell

    (1994)
  • R. Choudhary et al.

    Positive correlations between serum calcineurin activity and left ventricular hypertrophy

    Int J Cardiol

    (2005)
  • D. Fatkin et al.

    Genetics of dilated cardiomyopathy

    Heart Fail Clin

    (2010)
  • J.A. Towbin

    Toward an understanding of the cause of mitral valve prolapse

    Am J Hum Genet

    (1999)
  • R. Coral-Vazquez et al.

    Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism in the pathogenesis of cardiomyopathy and muscular dystrophy

    Cell

    (1999)
  • A.E. Deconinck et al.

    Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy

    Cell

    (1997)
  • R.M. Grady et al.

    Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy

    Cell

    (1997)
  • A. Sakamoto et al.

    Delineation of genomic deletion in cardiomyopathic hamster

    FEBS Lett

    (1999)
  • C. Huang et al.

    Characterization and in vivo functional analysis of splice variants of Cypher

    J Biol Chem

    (2003)
  • F. Sheikh et al.

    “Z”eroing in on the role of Cypher in striated muscle function, signaling, and human disease

    Trends Cardiovasc Med

    (2007)
  • Q. Zhou et al.

    Cypher, a striated muscle-restricted PDZ and LIM domain-containing protein, binds to alpha-actinin-2 and protein kinase C

    J Biol Chem

    (1999)
  • T. Wang et al.

    The immunophilin FKBP12 functions as a common inhibitor of the TGF-β family type I receptors

    Cell

    (1996)
  • T. Okadome et al.

    Characterization of the interaction of FKBP12 with the transforming growth factor-β type I receptor in vivo

    J Biol Chem

    (1996)
  • T. Jayaraman et al.

    FK506-binding protein associated with the calcium release channel (ryanodine receptor)

    J Biol Chem

    (1992)
  • R. Engberding et al.

    Isolated noncompaction of the left ventricular myocardium: a review of the literature two decades after the initial case description

    Clin Res Cardiol

    (2007)
  • R.H. Pignatelli et al.

    Clinical characterization of left ventricular noncompaction in children. A relatively common form of cardiomyopathy

    Circulation

    (2003)
  • B.J. Maron et al.

    Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention

    Circulation

    (2006)
  • T.K. Chin et al.

    Isolated noncompaction of left ventricular myocardium. A study of eight cases

    Circulation

    (1990)
  • J.A. Towbin et al.

    The failing heart

    Nature

    (2002)
  • F. Ichida et al.

    Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome

    Circulation

    (2001)
  • F. Scaglia et al.

    Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease

    Pediatrics

    (2004)
  • R.T. Grant

    An unusual anomaly of the coronary vessels in the malformed heart of a child

    Heart

    (1926)
  • R.M. Freedom et al.

    Congenital absence of the pulmonary valve associated with imperforate membrane type of tricuspid atresia, right ventricular tensor apparatus and intact ventricular septum: a curious developmental complex

    Eur J Cardiol

    (1979)
  • S. Bellet et al.

    Congenital heart disease with multiple cardiac anomalies: report of a case showing aortic atresia, fibrous scar in myocardium and embryonal sinusoidal remains

    Am J Med Sci

    (1932)
  • L.P. Elliott et al.

    Pulmonary atresia with intact ventricular septum

    Br Heart J

    (1963)
  • E. Oechslin et al.

    Isolated noncompaction of ventricular myocardium: a rare disorder

    Circulation

    (1993)
  • S.B. Bleyl et al.

    Xq28-linked noncompaction of the left ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals

    Am J Med Genet

    (1997)
  • Cited by (0)

    Funding Support: Dr Towbin is funded, in part, by the National Institutes of Health, National Heart, Lung and Blood Institute (R01 HL53392, and R01 HL087000, the Pediatric Cardiomyopathy Registry and Pediatric Cardiomyopathy Specimen Repository, respectively), and the Cincinnati Children's Kindervelt-Samuel Kaplan Chair in Cardiology.

    View full text